The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis
- PMID: 36700958
- DOI: 10.1007/s00011-023-01695-2
The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis
Abstract
Background: Increasing evidence indicates that N6-methyladenosine (m6A) modification of mRNAs has been shown to play a critical role in the occurrence and development of many diseases, while little is known about m6A modification in long non-coding RNAs (LncRNAs). Our study aims to investigate the potential functions of LncRNA m6A modifications in lipopolysaccharide (LPS)-induced mouse mesangial cells (MMCs), providing us with a new perspective on the molecular mechanisms of chronic glomerulonephritis (CGN) pathogenesis.
Methods: Differentially methylated LncRNAs were identified by Methylated RNA immunoprecipitation sequencing (MeRIP-seq). LncRNA-mRNA and LncRNA-associated LncRNA-miRNA-mRNA (CeRNA) networks were constructed by bioinformatics analysis. Furthermore, we utilized gene ontology (GO) and pathway enrichment analyses (KEGG) to explore target genes from co-expression networks. In addition, the total level of m6A RNA methylation and expression of methyltransferase and pro-inflammatory cytokines were detected by the colorimetric quantification method and western blot, respectively. Cell viability and cell cycle stage were detected by cell counting kit-8 (CCK-8) and flow cytometry.
Results: In total, 1141 differentially m6A-methylated LncRNAs, including 529 hypermethylated LncRNAs and 612 hypomethylated LncRNAs, were determined by MeRIP-seq. The results of GO and KEGG analysis revealed that the target mRNAs were mainly enriched in signal pathways, such as the NF-kappa B signaling pathway, MAPK signaling pathway, Toll-like receptor signaling pathway, and apoptosis signaling pathway. In addition, higher METTL3 expression was found in CGN kidney tissues using the GEO database. METTL3 knockdown in MMC cells drastically reduced the levels of m6A RNA methylation, pro-inflammatory cytokines IL6 and TNF-α, and inhibited cell proliferation and cycle progression.
Conclusions: Our findings provide a basis and novel insight for further investigations of m6A modifications in LncRNAs for the pathogenesis of CGN.
Keywords: Chronic glomerulonephritis; LncRNA; METTL3; MMCs; N6-methyladenosine.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Mesangial cell-derived CircRNAs in chronic glomerulonephritis: RNA sequencing and bioinformatics analysis.Ren Fail. 2024 Dec;46(2):2371059. doi: 10.1080/0886022X.2024.2371059. Epub 2024 Jul 1. Ren Fail. 2024. PMID: 38946402 Free PMC article.
-
N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.Epigenetics. 2024 Dec;19(1):2298058. doi: 10.1080/15592294.2023.2298058. Epub 2023 Dec 25. Epigenetics. 2024. PMID: 38145548 Free PMC article.
-
N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With Clostridium perfringens beta2 Toxin.Front Immunol. 2021 Nov 22;12:769204. doi: 10.3389/fimmu.2021.769204. eCollection 2021. Front Immunol. 2021. PMID: 34880865 Free PMC article.
-
Comprehensive analysis of m6A modification lncRNAs in high glucose and TNF-α induced human umbilical vein endothelial cells.Medicine (Baltimore). 2023 Mar 10;102(10):e33133. doi: 10.1097/MD.0000000000033133. Medicine (Baltimore). 2023. PMID: 36897718 Free PMC article.
-
The functions of N6-methyladenosine modification in lncRNAs.Genes Dis. 2020 Mar 19;7(4):598-605. doi: 10.1016/j.gendis.2020.03.005. eCollection 2020 Dec. Genes Dis. 2020. PMID: 33335959 Free PMC article. Review.
Cited by
-
The role of N-methyladenosine modification in acute and chronic kidney diseases.Mol Med. 2023 Dec 8;29(1):166. doi: 10.1186/s10020-023-00764-w. Mol Med. 2023. PMID: 38066436 Free PMC article. Review.
-
Overexpression of FTO inhibits excessive proliferation and promotes the apoptosis of human glomerular mesangial cells by alleviating FOXO6 m6A modification via YTHDF3-dependent mechanisms.Front Pharmacol. 2023 Sep 26;14:1260300. doi: 10.3389/fphar.2023.1260300. eCollection 2023. Front Pharmacol. 2023. PMID: 37822879 Free PMC article.
-
Construction of chronic glomerulonephritis‑related lncRNA‑mRNA regulatory network and lncRNA‑-miRNA‑mRNA ceRNA network by bioinformatics analysis.Exp Ther Med. 2023 Jul 7;26(2):403. doi: 10.3892/etm.2023.12102. eCollection 2023 Aug. Exp Ther Med. 2023. PMID: 37522060 Free PMC article.
-
Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis.Pharm Biol. 2023 Dec;61(1):1120-1134. doi: 10.1080/13880209.2023.2233998. Pharm Biol. 2023. PMID: 37477949 Free PMC article.
-
N6-methyladenosine methylation in kidney injury.Clin Epigenetics. 2023 Oct 21;15(1):170. doi: 10.1186/s13148-023-01586-7. Clin Epigenetics. 2023. PMID: 37865763 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources